ABCZF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
5.12B
CLLS
Price
$1.44
Change
+$0.01 (+0.70%)
Updated
Jun 5 closing price
Capitalization
151.84M
55 days until earnings call
Interact to see
Advertisement

ABCZF vs CLLS

Header iconABCZF vs CLLS Comparison
Open Charts ABCZF vs CLLSBanner chart's image
Abcam
PriceLoading...
Change-$0.00 (-0.00%)
VolumeN/A
Capitalization5.12B
Cellectis SA
Price$1.44
Change+$0.01 (+0.70%)
Volume$110.62K
Capitalization151.84M
ABCZF vs CLLS Comparison Chart
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCZF vs. CLLS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCZF is a StrongBuy and CLLS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ABCZF: $22.25 vs. CLLS: $1.44)
Brand notoriety: ABCZF and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCZF: 100% vs. CLLS: 158%
Market capitalization -- ABCZF: $5.12B vs. CLLS: $151.84M
ABCZF [@Biotechnology] is valued at $5.12B. CLLS’s [@Biotechnology] market capitalization is $151.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCZF’s FA Score shows that 1 FA rating(s) are green whileCLLS’s FA Score has 1 green FA rating(s).

  • ABCZF’s FA Score: 1 green, 4 red.
  • CLLS’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than ABCZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish.

  • CLLS’s TA Score: 5 bullish, 4 bearish.

Price Growth

ABCZF (@Biotechnology) experienced а 0.00% price change this week, while CLLS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CLLS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCZF($5.12B) has a higher market cap than CLLS($152M). ABCZF YTD gains are higher at: 0.000 vs. CLLS (-20.000).
ABCZFCLLSABCZF / CLLS
Capitalization5.12B152M3,369%
EBITDAN/A-9.46M-
Gain YTD0.000-20.000-
P/E Ratio1770.50N/A-
RevenueN/A41.5M-
Total CashN/A260M-
Total DebtN/A91.5M-
FUNDAMENTALS RATINGS
ABCZF vs CLLS: Fundamental Ratings
ABCZF
CLLS
OUTLOOK RATING
1..100
5056
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
8694
PRICE GROWTH RATING
1..100
7163
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
5040

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (22) in the Biotechnology industry is significantly better than the same rating for ABCZF (100) in the null industry. This means that CLLS’s stock grew significantly faster than ABCZF’s over the last 12 months.

ABCZF's Profit vs Risk Rating (70) in the null industry is in the same range as CLLS (100) in the Biotechnology industry. This means that ABCZF’s stock grew similarly to CLLS’s over the last 12 months.

ABCZF's SMR Rating (86) in the null industry is in the same range as CLLS (94) in the Biotechnology industry. This means that ABCZF’s stock grew similarly to CLLS’s over the last 12 months.

CLLS's Price Growth Rating (63) in the Biotechnology industry is in the same range as ABCZF (71) in the null industry. This means that CLLS’s stock grew similarly to ABCZF’s over the last 12 months.

ABCZF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for CLLS (100) in the Biotechnology industry. This means that ABCZF’s stock grew significantly faster than CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLLS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY593.05-2.88
-0.48%
SPDR® S&P 500® ETF
AAPL200.63-2.19
-1.08%
Apple
GME29.45-0.50
-1.67%
GameStop Corp
BTC.X101575.950000-3156.031200
-3.01%
Bitcoin cryptocurrency
TSLA284.70-47.35
-14.26%
Tesla

ABCZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCZF has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABCZF jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCZF
1D Price
Change %
ABCZF100%
N/A
IKNA - ABCZF
72%
Closely correlated
-2.61%
ATRA - ABCZF
69%
Closely correlated
+1.80%
CMVLF - ABCZF
62%
Loosely correlated
N/A
CLLS - ABCZF
58%
Loosely correlated
+0.70%
NUVL - ABCZF
52%
Loosely correlated
+1.65%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+0.70%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-1.64%
MDGL - CLLS
40%
Loosely correlated
-1.87%
PMVP - CLLS
38%
Loosely correlated
+2.37%
More